Global Deferasirox Market is expected to grow at a CAGR of 4.2% from 2020 to 2027

Deferasirox is an iron-chelating agent which is the most popular drug which is prescribed to reduce excess iron overload in blood disorder patients requiring frequent blood transfusion. It is available in different formulation for oral administration such as 90mg & 180mg film-coated tablets and tablet for suspension the composition are 125mg, 250mg, and 500mg, etc. […]